journal article·2023-12Open access

Single‐Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T‐Cell Lymphoma

Yi‐Qi Li, Chun‐Ling Luo, Jia‐Xin Jiang, Shuai He, Yang Liu, Wen‐Xin Yan, Yi Xia, Qian Cui, Ying Huang, Jing Quan Lim, Dachuan Huang, Izzah Nabilah Hussein, Yan Gao, Guo‐Wang Lin, Yi‐Hong Ling, Dong Ma, Yue‐Tong Zhang, Jason Yongsheng Chan, Pan‐Pan Wei, Xiao‐Xiao Wang, Chee Leong Cheng, Jie Xiong, Wei‐Li Zhao, Choon Kiat Ong, Soon Thye Lim, Hui‐Qiang Huang, Rou‐Jun Peng, Jin‐Xin Bei

Advanced Science· Volume 10· Issue 36

Abstract

Abstract Extranodal natural killer/T‐cell lymphoma (NKTCL) is an aggressive type of lymphoma associated with Epstein–Barr virus (EBV) and characterized by heterogeneous tumor behaviors. To better understand the origins of the heterogeneity, this study utilizes single‐cell RNA sequencing (scRNA‐seq) analysis to profile the tumor microenvironment (TME) of NKTCL at the single‐cell level. Together with in vitro and in vivo models, the study identifies a subset of LMP1+ malignant NK cells contributing to the tumorigenesis and development of heterogeneous malignant cells in NKTCL. Furthermore, malignant NK cells interact with various immunocytes via chemokines and their receptors, secrete substantial DPP4 that impairs the chemotaxis of immunocytes and regulates their infiltration. They also exhibit an immunosuppressive effect on T cells, which is further boosted by LMP1. Moreover, high transcription of EBV‐encoded genes and low infiltration of tumor‐associated macrophages (TAMs) are favorable prognostic indicators for NKTCL in multiple patient cohorts. This study for the first time deciphers the heterogeneous composition of NKTCL TME at single‐cell resolution, highlighting the crucial role of malignant NK cells with EBV‐encoded LMP1 in reshaping the cellular landscape and fostering an immunosuppressive microenvironment. These findings provide insights into understanding the pathogenic mechanisms of NKTCL and developing novel therapeutic strategies against NKTCL.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lymphoma Diagnosis and Treatment · Immune Cell Function and Interaction · Viral-associated cancers and disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Oncology in South China Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 China

Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou 510080 China

Lymphoma Translational Research Laboratory Cellular and Molecular Research National Cancer Centre Singapore 30 Hospital Boulevard Singapore 168583 Singapore

ONCO‐ACP Duke‐NUS Medical School 8 College Road Singapore 169857 Singapore

Microbiome Medicine Center Division of Laboratory Medicine Zhujiang Hospital Southern Medical University Guangzhou 510280 China

Division of Medical Oncology National Cancer Centre Singapore 30 Hospital Boulevard Singapore 168583 Singapore

Department of Pathology Singapore General Hospital 20 College Road Academia 169856 Singapore

State Key Laboratory of Medical Genomics Shanghai Institute of Hematology National Research Center for Translational Medicine Shanghai Rui Jin Hospital Shanghai Jiao Tong University School of Medicine 197 Rui Jin Er Road Shanghai 200025 China

Cancer and Stem Cell Biology Duke‐NUS Medical School 8 College Road Singapore 169857 Singapore

Director's Office National Cancer Centre Singapore 30 Hospital Boulevard Singapore 168583 Singapore

Office of Education Duke‐NUS Medical School Singapore 169857 Singapore

Funding

National Natural Science Foundation of China · Guangdong Innovative and Entrepreneurial Research Team Program · Tanoto Foundation

References (76)

Show source-provided references
1. 10.1186/s13045-017-0452-910.1186/s13045-017-0452-9 ↗
2. 10.1182/blood.V126.23.1521.152110.1182/blood.V126.23.1521.1521 ↗
3. 10.1200/JCO.2009.23.829510.1200/JCO.2009.23.8295 ↗
4. 10.1007/s00277-014-2137-610.1007/s00277-014-2137-6 ↗
5. 10.1200/JCO.2011.35.628710.1200/JCO.2011.35.6287 ↗
6. 10.1182/blood-2015-07-65519110.1182/blood-2015-07-655191 ↗
7. 10.1093/annonc/mdp41810.1093/annonc/mdp418 ↗
8. 10.1093/annonc/mdx31610.1093/annonc/mdx316 ↗
9. 10.1186/s13045-018-0559-710.1186/s13045-018-0559-7 ↗
10. 10.1182/blood-2016-12-75684110.1182/blood-2016-12-756841 ↗
11. 10.1038/s41392-020-00331-310.1038/s41392-020-00331-3 ↗
12. 10.1182/blood.202000724710.1182/blood.2020007247 ↗
13. Gao Y. · Blood · 2017 · 130 · 2797
14. 10.1182/blood-2020-13466510.1182/blood-2020-134665 ↗
15. 10.1016/j.ccell.2020.02.00510.1016/j.ccell.2020.02.005 ↗
16. 10.1016/S0046-8177(99)90147-810.1016/S0046-8177(99)90147-8 ↗
17. 10.1158/1078-0432.CCR-11-239510.1158/1078-0432.CCR-11-2395 ↗
18. 10.1016/S1470-2045(16)30148-610.1016/S1470-2045(16)30148-6 ↗
19. 10.1016/S1470-2045(19)30799-510.1016/S1470-2045(19)30799-5 ↗
20. 10.1038/nrc.2016.9210.1038/nrc.2016.92 ↗
21. 10.1146/annurev-pathmechdis-012418-01302310.1146/annurev-pathmechdis-012418-013023 ↗
22. 10.1038/s41375-018-0324-510.1038/s41375-018-0324-5 ↗
23. 10.1038/ng.335810.1038/ng.3358 ↗
24. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
25. 10.1016/j.cell.2018.05.06010.1016/j.cell.2018.05.060 ↗
26. 10.1038/s41591-018-0045-310.1038/s41591-018-0045-3 ↗
27. 10.1016/j.cell.2018.11.04310.1016/j.cell.2018.11.043 ↗
28. 10.1002/ijc.2596910.1002/ijc.25969 ↗
29. 10.1038/s41467-021-21043-410.1038/s41467-021-21043-4 ↗
30. 10.1016/j.jhep.2005.08.01310.1016/j.jhep.2005.08.013 ↗
31. 10.1016/j.semcancer.2006.07.00210.1016/j.semcancer.2006.07.002 ↗
32. 10.1182/blood-2009-05-22127510.1182/blood-2009-05-221275 ↗
33. 10.1016/j.cell.2022.08.02610.1016/j.cell.2022.08.026 ↗
34. 10.1158/2643-3230.BCD-21-009810.1158/2643-3230.BCD-21-0098 ↗
35. 10.1038/ni.321010.1038/ni.3210 ↗
36. 10.1182/blood-2013-02-48747010.1182/blood-2013-02-487470 ↗
37. 10.1038/nri386210.1038/nri3862 ↗
38. 10.1186/s13045-016-0341-710.1186/s13045-016-0341-7 ↗
39. 10.1126/science.abb375310.1126/science.abb3753 ↗
40. 10.1038/s41586-020-03075-w10.1038/s41586-020-03075-w ↗
41. 10.1038/s41579-019-0249-710.1038/s41579-019-0249-7 ↗
42. 10.1016/S0140-6736(19)30956-010.1016/S0140-6736(19)30956-0 ↗
43. 10.1186/s40880-018-0334-810.1186/s40880-018-0334-8 ↗
44. 10.18632/oncotarget.260810.18632/oncotarget.2608 ↗
45. Li X. · Int. J. Oncol. · 2006 · 29 · 595
46. 10.1016/j.canlet.2005.02.01010.1016/j.canlet.2005.02.010 ↗
47. 10.1590/1414-431x2023e1263810.1590/1414-431x2023e12638 ↗
48. 10.1200/JCO.2013.51.530410.1200/JCO.2013.51.5304 ↗
49. 10.1200/JCO.20.0170910.1200/JCO.20.01709 ↗
50. 10.1186/s12916-023-03040-010.1186/s12916-023-03040-0 ↗
51. 10.1038/nri.2017.7610.1038/nri.2017.76 ↗
52. 10.1016/j.cell.2021.09.01410.1016/j.cell.2021.09.014 ↗
53. 10.1016/j.cell.2023.07.03410.1016/j.cell.2023.07.034 ↗
54. 10.1038/s41591-018-0096-510.1038/s41591-018-0096-5 ↗
55. 10.1016/j.immuni.2019.11.01410.1016/j.immuni.2019.11.014 ↗
56. 10.1038/s41590-019-0321-510.1038/s41590-019-0321-5 ↗
57. 10.1056/NEJMoa150403010.1056/NEJMoa1504030 ↗
58. 10.1038/s41571-020-00449-x10.1038/s41571-020-00449-x ↗
59. 10.1038/s41568-019-0116-x10.1038/s41568-019-0116-x ↗
60. 10.1073/pnas.111058410810.1073/pnas.1110584108 ↗
61. 10.1182/blood-2008-12-19404310.1182/blood-2008-12-194043 ↗
62. 10.1182/blood.V92.7.247710.1182/blood.V92.7.2477 ↗
63. 10.1186/s13059-020-02210-010.1186/s13059-020-02210-0 ↗
64. 10.1128/JVI.02517-1210.1128/JVI.02517-12 ↗
65. 10.1016/j.cell.2019.05.03110.1016/j.cell.2019.05.031 ↗
66. 10.1016/j.cels.2019.03.00310.1016/j.cels.2019.03.003 ↗
67. 10.1126/science.125425710.1126/science.1254257 ↗
68. 10.1158/1078-0432.CCR-19-014810.1158/1078-0432.CCR-19-0148 ↗
69. 10.1038/s41586-020-2157-410.1038/s41586-020-2157-4 ↗
70. 10.1186/1471-2105-14-710.1186/1471-2105-14-7 ↗
71. 10.1038/s41467-019-09234-610.1038/s41467-019-09234-6 ↗
72. 10.1038/nmeth.446310.1038/nmeth.4463 ↗
73. 10.1038/nbt.285910.1038/nbt.2859 ↗
74. 10.1038/s41586-018-0414-610.1038/s41586-018-0414-6 ↗
75. 10.1038/s41596-020-0292-x10.1038/s41596-020-0292-x ↗
76. 10.1038/s41587-019-0114-210.1038/s41587-019-0114-2 ↗